BMT Clinical Trial Network at Stanford

Smita Bhatia

Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction

Hodgkin lymphoma

Radiation Oncology Pediatric oncology or childhood cancer

Thomas J O'Hare

Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Scott H Kaufmann

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Ronald Hoffman

A New Murine Model for MPN: Pathology and Therapy of NF-E2 Overexpression

Leukaemia

Hematology and hematologic malignancies Pathology

Sylvia Silver

The East Coast Aids and Cancer Specimen Resource

Non-Hodgkin lymphoma

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Brad H Pollock

Community Clinical Oncology Program Research Base

Leukaemia Non-Hodgkin lymphoma

Pediatric oncology or childhood cancer

Robert S Negrin

Bone Marrow Grafting for Leukemia and Lymphoma

Hodgkin lymphoma Non-Hodgkin lymphoma Leukaemia

Rainer F Storb

Hematopoietic Chimerism after Stem Cell Allografts

Leukaemia Non-Hodgkin lymphoma

Radiation Oncology Hematology and hematologic malignancies